Global Biosimilar Drug Market Professional Survey Report 2016 is a new market research publication announced by Reportstack. This report Mainly covers the following product types
The segment applications including
Segment regions including (the separated region report can also be offered)
USA
China
Europe
Japan
The players list (Partly, Players you are interested in can also be added)
Hospira
Sandoz
Teva Pharmaceutical Industries
Pfizer
Merck Sharp & Dohme
Celltrion
Amgen
Biogen
Mylan
Biocon
Dr. Reddy’s Laboratories
Boehringer Ingelheim GmbH
Intas Pharmaceuticals
LG Life Sciences
Emcure Pharmaceuticals
Probiomed
Biosidus
3SBio
WOCKHARDT
Sun Pharmaceutical Industries
Shanghai Fosun Pharmaceutical
Qilu Pharmaceutical
Allergan
Dongbao
Samsung Biologics
Zydus Cadila.
Dong-A Pharmaceutical
With no less than 15 top producers.
Segment regions including (the separated region report can also be offered)
USA
China
Europe
Japan
The players list (Partly, Players you are interested in can also be added)
Hospira
Sandoz
Teva Pharmaceutical Industries
Pfizer
Merck Sharp & Dohme
Celltrion
Amgen
Biogen
Mylan
Biocon
Dr. Reddy’s Laboratories
Boehringer Ingelheim GmbH
Intas Pharmaceuticals
LG Life Sciences
Emcure Pharmaceuticals
Probiomed
Biosidus
3SBio
WOCKHARDT
Sun Pharmaceutical Industries
Shanghai Fosun Pharmaceutical
Qilu Pharmaceutical
Allergan
Dongbao
Samsung Biologics
Zydus Cadila.
Dong-A Pharmaceutical
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - K Dose and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Dose, Cost, Gross margin etc.
To access full report with TOC, please visit Global Biosimilar Drug Market Professional Survey Report 2016
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
Snapshot of TOC with Companies Mentioned
8 Major Manufacturers Analysis of Biosimilar Drug
8.1 Hospira
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Hospira 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Hospira 2015 Biosimilar Drug Business Region Distribution Analysis
8.2 Sandoz
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Sandoz 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Sandoz 2015 Biosimilar Drug Business Region Distribution Analysis
8.3 Teva Pharmaceutical Industries
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Teva Pharmaceutical Industries 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Teva Pharmaceutical Industries 2015 Biosimilar Drug Business Region Distribution Analysis
8.4 Pfizer
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Pfizer 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Pfizer 2015 Biosimilar Drug Business Region Distribution Analysis
8.5 Merck Sharp & Dohme
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Merck Sharp & Dohme 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Merck Sharp & Dohme 2015 Biosimilar Drug Business Region Distribution Analysis
8.6 Celltrion
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Celltrion 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Celltrion 2015 Biosimilar Drug Business Region Distribution Analysis
8.7 Amgen
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Amgen 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Amgen 2015 Biosimilar Drug Business Region Distribution Analysis
8.8 Biogen
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Biogen 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Biogen 2015 Biosimilar Drug Business Region Distribution Analysis
8.9 Mylan
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Mylan 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Mylan 2015 Biosimilar Drug Business Region Distribution Analysis
8.10 Biocon
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Biocon 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Biocon 2015 Biosimilar Drug Business Region Distribution Analysis
8.11 Dr. Reddy’s Laboratories
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Dr. Reddy’s Laboratories 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Dr. Reddy’s Laboratories 2015 Biosimilar Drug Business Region Distribution Analysis
8.12 Boehringer Ingelheim GmbH
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Boehringer Ingelheim GmbH 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Boehringer Ingelheim GmbH 2015 Biosimilar Drug Business Region Distribution Analysis
8.13 Intas Pharmaceuticals
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Intas Pharmaceuticals 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Intas Pharmaceuticals 2015 Biosimilar Drug Business Region Distribution Analysis
8.14 LG Life Sciences
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 LG Life Sciences 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 LG Life Sciences 2015 Biosimilar Drug Business Region Distribution Analysis
8.15 Emcure Pharmaceuticals
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Emcure Pharmaceuticals 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Emcure Pharmaceuticals 2015 Biosimilar Drug Business Region Distribution Analysis
8.16 Probiomed
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Probiomed 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Probiomed 2015 Biosimilar Drug Business Region Distribution Analysis
8.17 Biosidus
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Biosidus 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Biosidus 2015 Biosimilar Drug Business Region Distribution Analysis
8.18 3SBio
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 3SBio 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 3SBio 2015 Biosimilar Drug Business Region Distribution Analysis
8.19 WOCKHARDT
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 WOCKHARDT 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 WOCKHARDT 2015 Biosimilar Drug Business Region Distribution Analysis
8.20 Sun Pharmaceutical Industries
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Sun Pharmaceutical Industries 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Sun Pharmaceutical Industries 2015 Biosimilar Drug Business Region Distribution Analysis
8.21 Shanghai Fosun Pharmaceutical
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Shanghai Fosun Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Shanghai Fosun Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
8.22 Qilu Pharmaceutical
8.22.1 Company Profile
8.22.2 Product Picture and Specifications
8.22.3 Qilu Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.22.4 Qilu Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
8.23 Allergan
8.23.1 Company Profile
8.23.2 Product Picture and Specifications
8.23.3 Allergan 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.23.4 Allergan 2015 Biosimilar Drug Business Region Distribution Analysis
8.24 Dongbao
8.24.1 Company Profile
8.24.2 Product Picture and Specifications
8.24.3 Dongbao 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.24.4 Dongbao 2015 Biosimilar Drug Business Region Distribution Analysis
8.25 Samsung Biologics
8.25.1 Company Profile
8.25.2 Product Picture and Specifications
8.25.3 Samsung Biologics 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.25.4 Samsung Biologics 2015 Biosimilar Drug Business Region Distribution Analysis
8.26 Zydus Cadila.
8.26.1 Company Profile
8.26.2 Product Picture and Specifications
8.26.3 Zydus Cadila. 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.26.4 Zydus Cadila. 2015 Biosimilar Drug Business Region Distribution Analysis
8.27 Dong-A Pharmaceutical
8.27.1 Company Profile
8.27.2 Product Picture and Specifications
8.27.3 Dong-A Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.27.4 Dong-A Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
8.1 Hospira
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Hospira 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Hospira 2015 Biosimilar Drug Business Region Distribution Analysis
8.2 Sandoz
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Sandoz 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Sandoz 2015 Biosimilar Drug Business Region Distribution Analysis
8.3 Teva Pharmaceutical Industries
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Teva Pharmaceutical Industries 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Teva Pharmaceutical Industries 2015 Biosimilar Drug Business Region Distribution Analysis
8.4 Pfizer
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Pfizer 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Pfizer 2015 Biosimilar Drug Business Region Distribution Analysis
8.5 Merck Sharp & Dohme
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Merck Sharp & Dohme 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Merck Sharp & Dohme 2015 Biosimilar Drug Business Region Distribution Analysis
8.6 Celltrion
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Celltrion 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Celltrion 2015 Biosimilar Drug Business Region Distribution Analysis
8.7 Amgen
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Amgen 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Amgen 2015 Biosimilar Drug Business Region Distribution Analysis
8.8 Biogen
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Biogen 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Biogen 2015 Biosimilar Drug Business Region Distribution Analysis
8.9 Mylan
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Mylan 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Mylan 2015 Biosimilar Drug Business Region Distribution Analysis
8.10 Biocon
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Biocon 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Biocon 2015 Biosimilar Drug Business Region Distribution Analysis
8.11 Dr. Reddy’s Laboratories
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Dr. Reddy’s Laboratories 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Dr. Reddy’s Laboratories 2015 Biosimilar Drug Business Region Distribution Analysis
8.12 Boehringer Ingelheim GmbH
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Boehringer Ingelheim GmbH 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Boehringer Ingelheim GmbH 2015 Biosimilar Drug Business Region Distribution Analysis
8.13 Intas Pharmaceuticals
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Intas Pharmaceuticals 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Intas Pharmaceuticals 2015 Biosimilar Drug Business Region Distribution Analysis
8.14 LG Life Sciences
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 LG Life Sciences 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 LG Life Sciences 2015 Biosimilar Drug Business Region Distribution Analysis
8.15 Emcure Pharmaceuticals
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Emcure Pharmaceuticals 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Emcure Pharmaceuticals 2015 Biosimilar Drug Business Region Distribution Analysis
8.16 Probiomed
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Probiomed 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Probiomed 2015 Biosimilar Drug Business Region Distribution Analysis
8.17 Biosidus
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Biosidus 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Biosidus 2015 Biosimilar Drug Business Region Distribution Analysis
8.18 3SBio
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 3SBio 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 3SBio 2015 Biosimilar Drug Business Region Distribution Analysis
8.19 WOCKHARDT
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 WOCKHARDT 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 WOCKHARDT 2015 Biosimilar Drug Business Region Distribution Analysis
8.20 Sun Pharmaceutical Industries
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Sun Pharmaceutical Industries 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Sun Pharmaceutical Industries 2015 Biosimilar Drug Business Region Distribution Analysis
8.21 Shanghai Fosun Pharmaceutical
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Shanghai Fosun Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Shanghai Fosun Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
8.22 Qilu Pharmaceutical
8.22.1 Company Profile
8.22.2 Product Picture and Specifications
8.22.3 Qilu Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.22.4 Qilu Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
8.23 Allergan
8.23.1 Company Profile
8.23.2 Product Picture and Specifications
8.23.3 Allergan 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.23.4 Allergan 2015 Biosimilar Drug Business Region Distribution Analysis
8.24 Dongbao
8.24.1 Company Profile
8.24.2 Product Picture and Specifications
8.24.3 Dongbao 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.24.4 Dongbao 2015 Biosimilar Drug Business Region Distribution Analysis
8.25 Samsung Biologics
8.25.1 Company Profile
8.25.2 Product Picture and Specifications
8.25.3 Samsung Biologics 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.25.4 Samsung Biologics 2015 Biosimilar Drug Business Region Distribution Analysis
8.26 Zydus Cadila.
8.26.1 Company Profile
8.26.2 Product Picture and Specifications
8.26.3 Zydus Cadila. 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.26.4 Zydus Cadila. 2015 Biosimilar Drug Business Region Distribution Analysis
8.27 Dong-A Pharmaceutical
8.27.1 Company Profile
8.27.2 Product Picture and Specifications
8.27.3 Dong-A Pharmaceutical 2015 Biosimilar Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.27.4 Dong-A Pharmaceutical 2015 Biosimilar Drug Business Region Distribution Analysis
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###
No comments:
Post a Comment